Presentation of NICE model at European Hematology Association

Results of a study by Mark Nuijten, Catherine Kielar, Holger Müller and Carl Peggs were presented at the 21th congress of the European Hematology Association (EHA), June 9 - 12, 216 in Copenhagen, Denmark: COST-EFFECTIVENESS ANALYSIS OF A DIRECTLY SELECTED CMV-SPECIFIC T-CELL THERAPY FOR MANAGEMENT OF CMV DISEASE IN PATIENTS POST ALLOGENEIC STEM CELL TRANSPLANTATION: A UK ANALYSIS.